Topic search: EXCIPIENTS

Search the Journal's archive for all articles tagged as being related to your selected topic. Click here to return to the list of all topics.

Excipeints Articles

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Sep/Oct 2025 Pg. 409-419	Microbiological and Physical Stability of Extemporaneous Oral Suspensions Compounded with SyrSpend® SF PH4 Author(s): Kegele Carolina Schettino, Dijkers Eli, Polonini Hudson
Sep/Oct 2025 Pg. 420-429	SyrSpend® SF PH 4 as a Safe Vehicle for Extemporaneous Oral Suspensions: Microbiological Stability of Seven APIs Author(s): Kegele Carolina Schettino, Dijkers Eli, Polonini Hudson
Sep/Oct 2025 Pg. 430-434	Physical Compatibility of Ertapenem and Meropenem in 0.45% Normal Saline and Plasma-Lyte A Author(s): Brown Berah, Schemmel Jacquelyn, Reinert Justin P, Baki Gabriella, Howard Mitchell S, Churchwell Mariann D
Sep/Oct 2025 Pg. 435-438	The Physical Compatibility of Orphenadrine Citrate with 0.45% Sodium Chloride, Lactated Ringer’s Solution, and Plasma-Lyte A Author(s): Ezema Chinenye G, Howard Mitchell S, Baki Gabriella, Churchwell Mariann D, Reinert Justin P
Sep/Oct 2025 Pg. 439-446	Long-Term Physicochemical Stability of a Morphine-Ketamine Admixture in Polypropylene Syringes at Room Temperature Author(s): Devis Luigi, Colsoul Marie-Lise, Bihin Benoît, Jamart Jacques, Soumoy Laura, Lombet Louise, Hecq Jean-Daniel, Galanti Laurence, Closset Mélanie, Catry Emilie
Jul/Aug 2025 Pg. 310-318	Antimicrobial Stability, pH, and Physical Appearance of Cardiovascular Drug Suspensions in SyrSpend® SF PH4: A Complementary Evaluation Author(s): Kegele Carolina Schettino, Dijkers Eli, Polonini Hudson
Jul/Aug 2025 Pg. 319-327	Antimicrobial Effectiveness and Physicochemical Stability of Compounded Psychiatric and Neurological Drug Suspensions in SyrSpend® SF PH4 Author(s): Kegele Carolina Schettino, Dijkers Eli, Polonini Hudson
May/Jun 2025 Pg. 222-238	Physicochemical and Microbiological Stability of Commonly Prescribed APIs in SyrSpend® SF PH4: A Comprehensive Compatibility Study Author(s): Kegele Carolina Schettino, Dijkers Eli, Polonini Hudson
May/Jun 2025 Pg. 239-253	Personalized Compounded Hair Loss Treatments: A Compatibility Assessment of the TrichoConcept™ Vehicle Line Author(s): Kegele Carolina Schettino, Marianni Bruna, Polonini Hudson Caetano
Jan/Feb 2025 Pg. 77-84	Biopharmaceutical Performance of DiluCap: A Line of Functional Excipients Enhancing Dissolution Profiles of Minoxidil, Finasteride, Melatonin, and Naltrexone Author(s): Kegele Carolina Schettino, Ferreira Anderson de Oliveira, Koulouridas Savvas, Polonini Hudson
Nov/Dec 2024 Pg. 460-467	Extemporaneous Compounding of Medicated Ointments Author(s): Nagel Karen, Ali Fatima, Al-Khudari Sarah, Khan Ayesha, Patel Khushbu, Patel Nikunj, Desai Archana
Sep/Oct 2024 Pg. 376-381	Quality Control: Water Activity Considerations for Beyond-use Dates Author(s): Allen Loyd V Jr
Jul/Aug 2024 Pg. 296-297	Basics of Compounding: Tips and Hints, Part 4: Lollipops/Lozenges, Gummy Bears, Patches, Flavoring/Coloring, Sweeteners, and Packaging Author(s): Allen Loyd V Jr
May/Jun 2024 Pg. 226-227	Recommended Tips for Treating Veterinary Patients Author(s): Bramwell Bethany L, Williams LaVonn A
Nov/Dec 2023 Pg. 454-460	Highlighting the Benefits of AlpaWash in Wound Care: Case Reports in Small Animals Author(s): Semighini Flavia, Fornaciari Lais de Azevedo, Pinheiro Vanessa, Lupatini Rodrigo, Haiub Halema, Cull Erica, Sidhu Raman
Nov/Dec 2023 Pg. 474-481	Nonsterile Basics of Compounding: Using U.S. Food and Drug Administration-approved Commercial Products as Ingredients Author(s): Allen Loyd V Jr
Nov/Dec 2023 Pg. 522-527	Development of a Novel Co-processed Excipitient Comprising of Xylitol, Mannitol, Microcrystalline Cellulose, and Crospovidone for the Compounding of Memantine Hydrochloride Orally Disintegrating Tablet Author(s): Hazdi Siti Nursaqifah, Phang Hiu Ching, Ng Zhi Qi, Chew Yik Ling, Uddin ABM Helal, Sarker Zaidul Islam, Lee Siew-Keah, Liew Kai Bin
Sep/Oct 2023 Pg. 382-385	Excipients and Adverse Events Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 397-409	Basics of Sterile Compounding: Sterile Basics of Compounding Intravenous Admixtures, Part 4: Physicochemical Considerations Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 431-439	The Influence of Polymers, Surfactants, and Other Excipients on Naproxen Sodium Release from Matrices Prepared and the Effect of These Additives on the Swelling Rate of the Tablet Author(s): Alhmoud Hassan, Akkam Yazan, Omari Derar, Alghananim Alaa, Melhem Mohammad Bani
Jul/Aug 2023 Pg. 270-276	Case Report in Equine: Highlighting the Benefits of Medisca CopaSil in Burn Scar Management Author(s): Heuerman Jason, Haiub Halema, Cull Erica, Lupatini Rodrigo, Shrum Brandon, Sidhu Raman
Jul/Aug 2023 Pg. 278-283	Topical Vehicles: A Dermatologist's Perspective Author(s): Adame Stephanie, Collins Michael E, Korman Abraham M
Jul/Aug 2023 Pg. 295-302	Nonsterile Basics of Compounding: Compounding with Antioxidants, Part 1: An Overview Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 329	Trihexyphenidyl Hydrochloride 1-mg/mL Oral Liquid, Alcohol-free Author(s): Allen Loyd V Jr
Jul/Aug 2023 Pg. 330-339	Physiochemical and Microbiological Stability of Azathioprine Suspensions in PCCA Base, SuspendIt Author(s): Pramar Yahoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
May/Jun 2023 Pg. 218-221	Nonsterile Basics of Compounding: Compounding with Humectants Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 223-229	Sterile Basics: Intravenous Admixture Compounding, Part 2: Parenteral Vehicle Considerations Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 240-249	An Alternative Approach to Tablet Splitting and Grinding for Medication Administration Author(s): Taneja Rajneesh, Scarim Joseph, Pande Poonam G, Scarim Anthony, Nahata Milap C, Jew Rita K, Inabathina Koteswara Rao
May/Jun 2023 Pg. 250-255	Stability of Omeprazole Extemporaneous Oral Solution in Chopin Base Author(s): Spennacchio Antonio, Lopedota Angela Assunta, la Forgia Flavia Maria, Fontana Sergio, Denora Nunzio, Lopalco Antonio
May/Jun 2023 Pg. 256-262	Extemporaneous Topical Minoxidil Solutions for the Treatment of Alopecia: Stability Studies and Incorporation Tests of Active Ingredients in ALOPLUS FAST Base Author(s): Spennacchio Antonio, Lopedota Angela Assunta, Lopalco Antonio, Dibenedetto Maria Teresa, la Forgia Flavia Maria, Fontana Sergio, Franco Massimo, Denora Nunzio
Mar/Apr 2023 Pg. 149-151	Pilocarpine Hydrochloride 0.3% w/v Solution Author(s): Allen Loyd V Jr
Mar/Apr 2023 Pg. 160-168	Physicochemical and Microbiological Stability of Pyrimethamine in Paraben-free PCCA Base, SuspendIt Author(s): Pramar Yashoda V, Mandal Tarum K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
Jan/Feb 2023 Pg. 6-10	Case Report of Anal Fissures and Hemorrhoids Treated with Compounded Cromolyn Sodium and Naltrexone Hydrochloride in MEDISCA's SPG SUPPOSI-BASE Author(s): Earlywine Kerry, Haiub Halema, Cull Erica, Lupatini Rodrigo, Sidhu Raman
Jan/Feb 2023 Pg. 24-29	Basics: A Review: In Situ Gel Dosage Forms for Herbal Medicine Delivery Author(s): Rachmawati Putriana
Jan/Feb 2023 Pg. 51	Clozapine 20 mg/mL in Ora-Sweet and Ora-Plus Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 52	Dapsone 2 mg/mL in Ora-Sweet and Ora-Plus Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 53	Erlotinib 10 mg/mL in Ora-Sweet and Ora-Plus Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 58-59	Suspension Solution, Sugar Free Author(s): Allen Loyd V Jr
Jan/Feb 2023 Pg. 72-77	Physicochemical Stability of the Extemporaneous Ibuprofen Oral Suspension in "Wagner" Base Author(s): Spennacchio Antonio, Lopedota Angela, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
Jan/Feb 2023 Pg. 78-87	Design and Development of Agglomerated Isomalt Author(s): Chauhan Nikita N, Patel Jayvadan K
Nov/Dec 2022 Pg. 446-466	Compounding with Biotechnology Products, Part 2: Product-specific Considerations Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 468-472	Unlicensed Transdermal Medications in Feline Patients: Three Case Reports Author(s): Urwin Craig, Jean Linda, Carvalho Maria, Robson-Laws Michael
Nov/Dec 2022 Pg. 508	Bacitracin 0.01% and Phenol 0.1% in Cetaphil Lotion Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 370-377	Recent Formulation Advances and Preparation of Orally Disintegrating Tablets Author(s): Ejeta Fikadu
Jul/Aug 2022 Pg. 283-291	Evaluation of the Physical-chemical Characteristics and Biopharmaceutical Performance of Dilu-Cap: A Complete Line of Excipients for Hard-shell Capsules Author(s): de Oliveira Ferreira Anderson, Polonini Hudson
Jul/Aug 2022 Pg. 319	Cetrimide Lotion Author(s): Allen Loyd V Jr
Jul/Aug 2022 Pg. 342-351	Physicochemical and Microbiological Stability of Amitriptyline Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
May/Jun 2022 Pg. 195-200	A Procedure for Tablet Production by Using the 3D Molding Technology and Powder Micromeritics Properties Author(s): Mady Omar
May/Jun 2022 Pg. 255-263	Application of Co-processed Excipient as a Novel Method to Compound Orally Disintegrating Tablets Author(s): Liew Kai Bin, Hii Shou Hui, Chew Yik Ling, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam
Mar/Apr 2022 Pg. 118-126	Basics of Compounding: Compounding Nonsterile Preparations Using Cyclodextrins Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 140	Alprazolam 1 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 141	Codeine Phosphate 3 mg/mL in Ora-Sweet Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 142	Ketoconazole 2%, Terbenafine 1%, Acetic Acid 2%, and Urea 2% in Dimethyl Sulfoxide Nail Polish Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 143	Lorazepam 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 145	Naproxen 25 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 146	Phenobarbital 10 mg/mL in SyrSpend SF pH4, Cherry Flavored Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 147	Phenytoin 15 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 149	Pyridoxine Hydrochloride 50 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 150-154	Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates) Author(s): Brandin Thibaut, Wasilewski Maya, Panuccio Camille, Bouguergour Cyrielle, Primas Nicolas, Lamy Edouard, Jean Christophe, Bertault-Peres Pierre, Rathelot Pascal, Curti Christophe, Vanelle Patrice
Mar/Apr 2022 Pg. 155-162	Comparison of Solvent Casting and Spray Casting Method on Compounding of an Orally Disintegrating Film Containing Amlodipine Besylate Author(s): Ruslan Mohamad Fariz Haiqal, Janakiraman Ashok Kumar, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai
Mar/Apr 2022 Pg. 163-174	Molding as Innovative Technology for Personalized Tablet Production Author(s): Mady Omar Y, Al-Shoubki Adam A, Hagag Youssef, Ibrahim Bakry, Donia Ahmed A
Jan/Feb 2022 Pg. 34-38	Basics: Considerations and Background Information for Counseling Patients Using Compounded Suppositories Author(s): Allen Loyd V Jr
Jan/Feb 2022 Pg. 41-49	Sterile Basics: Compounding Sterile Preparations with Cyclodextrins Author(s): Allen Loyd V Jr
Nov/Dec 2021 Pg. 486-489	Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 12: Sorbents (Adsorbents and Absorbents) Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 364-371	Filling the Gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products Author(s): Uttaro Elizabeth, Zhao Fang, Schweighardt Anne
Sep/Oct 2021 Pg. 396-400	Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 11: Drug Tastes: Innate, Induced, and Improved Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 403-408	Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 11: Particulate Issues --- Silicone Oil in Vials, Cartridges, and Syringes Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 410	Calculations Author(s): Stockton Shelly J
Jul/Aug 2021 Pg. 288-295	Safety Aspects of Extemporaneous Prescriptions Prescribed by Latvian Healthcare Specialists Author(s): Kiselova Olga, Maurina Baiba, Sidlovska Venta
Jul/Aug 2021 Pg. 304-309	Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 10: Rectal Suppository Bases Author(s): Allen Loyd V Jr
Jul/Aug 2021 Pg. 336-343	Compatibility of Estradiol, Estriol, Estrone, Progesterone, and Testosterone Single Formulation in Fitalite, Versatile, or HRT Supreme Cream Base Author(s): Polonini Hudson C, Dijkers Eli, Ferreira Anderson O, Zander Clark, Taylor Sarah
Jul/Aug 2021 Pg. 344-351	Stability of Compounded Topical Nifedipine in Cream, Gel, and Ointment Bases Author(s): Teimouri Arezou, Yeung Pollen, Agu Remigius U
May/Jun 2021 Pg. 218-221	Basics of Compounding: Excipients Used in Nonsterile Compounding: Diluents Author(s): Allen Loyd V Jr
May/Jun 2021 Pg. 236-240	Stability Evaluation of Minoxidil in FOAMIL Foam Base with Bracketing Study Design Author(s): Lupatini Rodrigo, Sidhu Raman, Patel Harshad, Bichar Katia
May/Jun 2021 Pg. 241-245	In Vitro Release Tests of Ketoprofen from Pluronic Lecithin Organogel versus Lipoderm Using Immersion Cells and the Phoenix DB-6 Dry Heat Diffusion Tester Author(s): McKinney Rachael D, Dunbar Jacob R
Mar/Apr 2021 Pg. 115-124	Quality Control: Minor Chapters, Major Impacts: What United States Pharmacopeia Chapters <51>, <61>, <62>, and <1207> Mean for Your Compounding Practice Author(s): Kelley Brian
Mar/Apr 2021 Pg. 126-128	Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 8: Humectants Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 142	Amlodipine 1-mg/mL in Oral Mix Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 143	Canine Soft Chew Base (Veterinary) Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 144	Eslicarbazepine Acetate 40-mg/mL in Ora-Plus with Ora-Sweet or Ora-Sweet SF Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 145	Levodopa/Carbidopa 5.0/1.25 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 156-162	Stability of Fagron's Phytobase Cream Compounded with Various Hormones Author(s): Wynn Tom, Taylor Sarah, Zander Clark
Mar/Apr 2021 Pg. 169-175	Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A
Jan/Feb 2021 Pg. 40	Calculations Author(s): Stockton Shelly J
Jan/Feb 2021 Pg. 44	Clonidine 0.01-mg/mL in Oral Mix and Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 45	Cyclophosphamide 10 mg/mL in Oral-Plus or Simple Syrup Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 46	Diclofenac Sodium 5 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 47	Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2021 Pg. 48-51	Design and Performance of an Inexpensive Water Activity Meter Author(s): Gilda Sagar S, Schober Joseph M, McPherson Timothy
Jan/Feb 2021 Pg. 52-61	Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration Author(s): Lu Juan, Liu Qiang, Kupiec Thomas C, Vail Herbert, Lynch Leslie R, Fam David S, Vu Nicole T
Jan/Feb 2021 Pg. 82-87	Physical-chemical Stability of Compounded Sildenafil 100-mg Rapid-dissolving Tablets Author(s): Cheung Matthew, Zhao Fang, Dave Vivek S
Nov/Dec 2020 Pg. 482-490	Stability of Compounded Diltiazem Hydrochloride in Cream, Ointment, and Gel Formulations for Topical Use Author(s): Teimouri Arezou, Yeung Pollen, Agu Remigius U
Nov/Dec 2020 Pg. 501-508	Drug-release Assessment of Compounded Topical Nifedipine and Diltiazem in Commonly Used Bases for Wound Healing Author(s): Teimouri Arezou, Yeung Pollen, Agu Remigius U
Nov/Dec 2020 Pg. 509-514	Investigation of Filler Effects on the Compounding of Freeze-dried Orodispersible Tablets Containing Annona muricata Extract Author(s): Azman Syahiera Ezzah Noor, Abd Razak Fashli Syafiq, Kamal Wan Hamirul Bahrin Wan, Zheng Gan Kok, Ming Long Chiau, Uddin ABM Helal, Sarker Zaidul Islam, Bin Liew Kai
Nov/Dec 2020 Pg. 515-518	Development and Evaluation of an Anti-aging Cosmetic Formulation Exploring Antioxidant Potential of Vitis vinifera L. Author(s): Carneiro Jaqueline, Marques Gonçalves Melissa, Vicente Pereira Airton
Sep/Oct 2020 Pg. 388-395	Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 7: Compounding with Surfactants Author(s): Allen Loyd V Jr
Sep/Oct 2020 Pg. 397-402	Intravenous Admixture Preparation Considerations, Part 6: pH Considerations -- Applications Author(s): Allen Loyd V Jr
Sep/Oct 2020 Pg. 408-412	Always the Right Dose? Content Uniformity in Over 100 Different Formulations Tested Author(s): Dijkers Eli, Polonini Hudson, de Oliveira Ferreira Anderson
Sep/Oct 2020 Pg. 413-419	Physicochemical Stability of Compounded Allopurinol Suspensions in PCCA Base, SuspendIt Author(s): Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A
May/Jun 2020 Pg. 206-212	Basics: Excipients Used in Nonsterile Compounding, Part 6: Compounding with Viscosity-increasing Agents Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 246-251	Alcohol-free Extemporaneous Formulations of Furosemide Are Chemically and Physically Stable in Ora-Blend Products for 30 Days Author(s): Svirskis Darren, Jaffer Johaina, Agarwal Priyanka, Khan Ayeshah, Kaur Jaskarn, Cheng Alan, Hanning Sara
May/Jun 2020 Pg. 252-262	Stability of Azathioprine, Clonidine Hydrochloride, Clopidogrel Bisulfate, Ethambutol Hydrochloride, Griseofulvin, Hydralazine Hydrochloride, Nitrofurantoin, and Thioguanine Oral Suspensions Compounded with SyrSpend SF pH4 Author(s): Polonini Hudson, Loures da Silva Sharlene, Neves Cunha Carolina, de Oliveira Ferreira Anderson, Anagnostou Korina, Dijkers Eli
Mar/Apr 2020 Pg. 98-102	Compounding Pearls -- Wound Care: Base Selection Author(s): Riepl Mike
Mar/Apr 2020 Pg. 114-118	Basics of Nonsterile Compounding: Excipients Used in Nonsterile Compounding, Part 5: Compounding Using Solvents and Cosolvent Systems Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 130	Acetazolamide 25 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 131	Cholecalciferol 50,000 IU/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 133	Minocycline Hydrochloride 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 134	Nitrofurantoin 2 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 135	Propylthiouracil 5 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 136	Quinidine Sulfate 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 137	Terbinafine 25 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 138	Topiramate 5 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 139	Valsartan 4 mg/mL in Syrup NF Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 163-167	Feasibility Study of Asthma Cream Author(s): Kuang Andrew
Mar/Apr 2020 Pg. 168-175	Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel Author(s): Dahal Amit, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard
Jan/Feb 2020 Pg. 38-43	Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 44-50	Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 472-477	Basics: Excipients Used in Nonsterile Compounding, Part 3: Preservatives Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 486	Gabapentin 50-mg/mL in SyrSpend SF Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 487	Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 488	Pregabaline 20 mg/mL in SyrSpend SR pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 489	Riboflavin 10 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 490	Sulfasalazine 100 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 491	Tacrolimus Monohydrate 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 492	Tadalafil 5 mg/mL in Oral-Plus:Ora-Sweet (1:1) Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 493	Ursodiol 30 mg/mL in SyrSpend SF Cherry Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 494	Verapmail Hydrochloride 50 mg/mL in SyrSpend SF Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 495	Zonisamide 10 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Nov/Dec 2019 Pg. 496-503	Compounded Topical Gabapentin for Neuropathic Pain: Does Choice of Base Affect Efficacy? Author(s): Shakshuki Ayah, Agu Remigius U
Nov/Dec 2019 Pg. 504-510	Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid Author(s): Chuong Monica, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G
Nov/Dec 2019 Pg. 519-527	Physicochemical Stability of Compounded Amlodipine Besylate Suspensions in PCCA Base, SuspendIt Author(s): Graves Richard A, Mandal Tarun K, Bostanian Levon A, Nguyen Anh TQ, Swopes Demikka, Morris Tommy C, Pramar Yashoda V
Sep/Oct 2019 Pg. 366-375	Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 3 Author(s): Zur Eyal
Sep/Oct 2019 Pg. 393-396	Basics: Excipients Used in Nonsterile Compounding, Part 2 Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 288-293	Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 2 Author(s): Zur Eyal
Jul/Aug 2019 Pg. 299-303	Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 2: Microbiological Testing Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 305-311	Basics: Excipients Used in Nonsterile Compounding, Part 1 Author(s): Allen Loyd V Jr
May/Jun 2019 Pg. 221-228	Basics of Sterile Compounding: Vehicles Used in Sterile Compounding Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 135-143	Basics of Compounding: Summary of the Official United States Pharmacopeia Monographs for Compounded Preparations Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 149	Dexamethasone 2 mg/g Topical Paste, Veterinary Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 59	Orodispersible Film Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 65-69	Transdermal Delivery of Metformin Hydrochloride from a Semisolid Vehicle Author(s): Polonini Hudson, Lopes Cândido Paulo José, Andrade Junquiera Laura, Loures Sharlene, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson
Jan/Feb 2019 Pg. 82-87	Stability Assessment of Topical Amitriptyline Extemporaneously Compounded with Lipoderm Base, PLO Gel Mediflo 30, and Emollient Cream Author(s): Shakshuki Ayah, Agu Remigius U
Nov/Dec 2018 Pg. 480-489	Basics of Compounding: Vehicles for Compounded Oral Liquid Medications: A Review Author(s): Cutaia Kara, Chablani Lipika, Zhao Fang
Nov/Dec 2018 Pg. 492	Clonazepam 0.2 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 493	Diltiazem Hydrochloride 12 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 494	Enalapril Maleate 1 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 495	Hydrocortisone 2 mg/mL in Inorpha Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 496	Hydroxyurea 100 mg/mL in Ora-Plus:Ora-Sweet, Ora-Plus: Ora-Sweet SF, Ora-Blend or Oral-Blend SF Oral Suspensions Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 497	Prednisone 5 mg/mL ir Oral Mix Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2018 Pg. 498-503	Gabapentin in Elastic Liposomes: Preparation, Characterization, Drug Release, and Penetration Through Porcine Skin Author(s): Le Uyen Minh, Baltzley Sarah, AlGhananeem Abeer
Nov/Dec 2018 Pg. 504-511	Physical and Chemical Stability of Estriol 0.025% to 1% Vaginal Creams (VersaBase) Author(s): Ip Kendice, Shan Ashley, Yan Wei, Banov Daniel
Nov/Dec 2018 Pg. 516-526	Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF pH4 Author(s): Polonini Hudson, da Silva Sharlene Loures, Brandão Marcos Antônio Fernandes, Bauters Tiene, De Moerloose Barbara, Ferreira Anderson de Oliveira
Sep/Oct 2018 Pg. 409	Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 424-432	A Cold Process Preparation of Vetiveria zizanioides (L.) Nash Oil Lotions using Simulgel FL as an Emulsifier Author(s): Songkro Sarunyoo, Pengmak Somuredee, Seajung Pornyamol, Maneenuan Duangkhae, Kaewnopparat Nattha
Sep/Oct 2018 Pg. 433-439	Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding Author(s): Zhao Fang, Dave Vivek S, Mar Mazin Z, Perri Jonathan R
Jul/Aug 2018 Pg. 288-293	Quality Control: Water Activity Considerations for Beyond-use Dates Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 294-300	Basics of Compounding--Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 2 Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 303-312	Basics of Sterile Compounding: Criteria for Determining Beyond-use Dating Author(s): Martin Matt
Jul/Aug 2018 Pg. 316	Anhydrous Medium-chain Triglycerides Gel Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 182-188	Pitch Ointment: Applications in Scar and Wound Management Author(s): Kloesel Lawson, Carvalho Maria, Banov Fabiana
May/Jun 2018 Pg. 220-228	Basics of Compounding–Nonsterile: Compounding Self-emulsifying Drug Delivery Systems and Other Self-emulsifying Lipid Formulations, Part 1 Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 232	Anhydrous Silicon Base Topical Gel Vehicle Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 247-251	Comparison of Rheological and Sedimentation Behavior of Commercially Available Suspending Vehicles for Oral Pharmaceutical Preparations Author(s): Visser J Carolina, ten Seldam Inge E J, van der Linden Isabella J, Hinrichs Wouter L J, Veenendaal Reinier F H, Dijkers Eli C F, Woerdenbag Herman J
Mar/Apr 2018 Pg. 137-143	Basics of Compounding: Compounding Microemulsions Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 146	Clonidine Hydrochloride 10 mg/mL in Inorpha Solution Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 164-171	The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions Author(s): Svirskis Darren, Lin Shao-Wei, Brown Helen, Sangaroomthong Annie, Shin Daniel, Wang Ziqi, Xu Hongtao, Dean Rebecca, Vareed Preetika, Jensen Maree, Wu Zimei
Jan/Feb 2018 Pg. 51	Mercaptopurine 50 mg/mL in Ora-Sweet and Ora-Plus Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 52	Metronidazole 50 mg/mL in Ora-Blend Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 53	Miconazole 10% in Recura Topical Cream Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 54	Naproxen 25 mg/mL in Oral Mix or Oral Mix SF Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 55	Penicillamine-D 50 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 56	Ranitidine 15 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 58	Thalidomide 20 mg/mL in Ora-Plus and Ora-Sweet Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 59	Voriconazole 40-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 60-65	Effects of Compounded Stanford Modified Oral Rinse (MucoLox) on the Survival and Migration of Oral Keratinocytes and Fibroblasts: Implications for Wound Healing Author(s): Song Guiyun, Banov Daniel, Bassani August S
Jan/Feb 2018 Pg. 66-75	Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension Author(s): Manchanda Arushi, Laracy Melissa, Savji Taslim, Bogner Robin H
Nov/Dec 2017 Pg. 446-452	Feline Transdermal Formulation Considerations Author(s): Forsythe Lauren Eichstadt
Nov/Dec 2017 Pg. 454-461	Orodispersible Films for Compounding Pharmacies Author(s): Ferreira Anderson O, Brandão Marcos Antônio F, Raposo Francisco José, Polonini Hudson C, Raposo Nádia Rezende Barbosa
Nov/Dec 2017 Pg. 471-479	Basics of Compounding: Hot Melt Extrusion Author(s): DePasquale Seth
Nov/Dec 2017 Pg. 490	Amitriptyline 20 mg/mL in OraPlus:OraSweet Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 500-512	To Flavor or Not to Flavor Extemporaneous Omeprazole Liquid Author(s): Chuong Monica C, Taglieri Catherine A, Kerr Stephen G
Nov/Dec 2017 Pg. 530-535	Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives Author(s): Trimble John O, Light Bob
Sep/Oct 2017 Pg. 409	Carbamazepine 25-mg/mL in SyrSPend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Sep/Oct 2017 Pg. 418-425	Kinetic Analysis of Drug Release from Compounded Slow-release Capsules of Liothyronine Sodium (T3) Author(s): Bakhteyar Hamid, Cassone Clayton, Kohan Hamed Gilzad, Sani Shabnam N
Sep/Oct 2017 Pg. 430-435	Physicochemical Stability of an Oral Suspension of Trimethoprim 20 mg/mL in Combination with Sulfadiazine 200 mg/mL in PCCA Base SuspendIt Author(s): Graves Richard A, Phan Kelly V, Bostanian Levon A, Mandal Tarun K, Pramar Yashoda V
Jul/Aug 2017 Pg. 277-280	Component Selection for Sterile Compounding Author(s): Dilzer Richard H
Jul/Aug 2017 Pg. 293-298	Basics of Compounding: 3D Printing: Pharmacy Applications, Part 3: Compounding, Formulation Considerations, and the Future Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 301-308	Basics of Sterile Compounding: Excipients Used in Injections Author(s): Akers Michael J
Jul/Aug 2017 Pg. 322-329	Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox) Author(s): Ip Kendice, Carvalho Maria, Shan Ashley, Banov Daniel
Jul/Aug 2017 Pg. 334-338	Stability of Spironolactone Oral Suspension in PCCA Base, SuspendIt Author(s): Graves Richard, Phan Kelly V, Bostanian Levon A, Mandal Tarun K, Pramar Yashoda V
Jul/Aug 2017 Pg. 339-346	Stability of Acetazolamide, Baclofen, Dipyridamole, Mebeverine Hydrochloride, Propylthiouracil, Quinidine Sulfate, and Topiramate Oral Suspensions in SyrSpend SF PH4 Author(s): de Oliveira Ferreira Anderson, Polonini Hudson, Loures da Silva Sharlene, Buzinari Aglio Natália Cristina, Abreu Jordana, Fernandes Brandão Marcos Antônio
May/Jun 2017 Pg. 205-211	Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report Author(s): Jones Nat, Carvalho Maria, Branvold-Herr Andrea
May/Jun 2017 Pg. 215-220	Basics of Compounding: 3D Printing--Pharmacy Applications, Part 2 Author(s): Allen Loyd V Jr
May/Jun 2017 Pg. 240-241	Updated Stability Data for Midazolam, Oseltamivir Phosphate, and Propranolol Hydrochloride in SyrSpend SF and Minoxidil in Espumil Author(s): Dijkers Eli, Nanhekhan Valerie, Thorissen Astrid
May/Jun 2017 Pg. 255-263	Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions Author(s): de Oliveira Ferreira Anderson, Polonini Hudson C, Loures da Silva Sharlene, Cerqueira de Melo Victor Augusto, de Andrade Laura, Fernandes Brandão Marcos Antônio
Mar/Apr 2017 Pg. 105-108	Restructuring the Art of Health by Pharmacists: Formulation Designs with Oral Vehicles--Teaching Pharmacy Students Author(s): Benischek Rita
Mar/Apr 2017 Pg. 154-159	Stability of Two Antifungal Agents, Fluconazole and Miconazole, Compounded in HUMCO RECURA Topical Cream to Determine Beyond-Use Date Author(s): Gautam Pradeep, Light Bob, Purvis Troy
Mar/Apr 2017 Pg. 160-163	Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions Author(s): Kabiche Djamila, Balde Issa-Bella, Majoul Elyes, Kabiche Sofiane, Bourguignon Elodie, Fontan Jean-Eudes, Cisternino Salvatore, Schlatter Joel
Jan/Feb 2017 Pg. 39-45	Basics of Compounding with Dilutions and Concentrates Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 485-493	Basics of Compounding: Clinical Pharmaceutics, Part 2 Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 526-527	PostScription: What Lies Beneath: Potentially Harmful Excipients to Avoid when Compounding for Small Animals--A Note of Caution Author(s): Rost Erika
Sep/Oct 2016 Pg. 367-374	Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy Author(s): Kochanowska-Karamyan Anna J
Sep/Oct 2016 Pg. 389-396	Basics of Compounding: Clinical Pharmaceutics, Part 1 Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 415	Tromethamine Injection Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 421-425	Stability of Clindamycin Hydrochloride in PCCA Base SuspendIt Author(s): Pramar Yashoda V, Graves Richard A, Ledet Grace A, Phan Kelly V, Bostanian Levon A, Mandal Tarun K
Sep/Oct 2016 Pg. 426-434	Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions Author(s): Polonini Hudson C, Loures Sharlene, de Araujo Edson Peter, Brandão Marcos Antônio F, Ferreira Anderson O
Sep/Oct 2016 Pg. 435-437	Stability of Sodium Nitroprusside in 5% Dextrose Stored at 4°C in Polypropylene Syringes Protected from Light Author(s): Anderson Collin R, Collins Deborah, Laursen Trevor, Arave Trevor, Helm Michael
Jul/Aug 2016 Pg. 277-280	Case Report: Pediatric Scar Management After Open-heart Surgery Author(s): Phan Ha, Harger Beau, Estrada Nick
Jul/Aug 2016 Pg. 298-305	Basics of Compounding: Compounding Films Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 338-342	Stability of Ampicillin in Normal Saline and Buffered Normal Saline Author(s): Maher Moureddine, Jensen Kara J, Lee David, Nix David E
May/Jun 2016 Pg. 209-214	Basics of Compounding: Special Capsules Author(s): Allen Loyd V Jr
May/Jun 2016 Pg. 250-256	Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives Author(s): Trimble John, Light Bob
May/Jun 2016 Pg. 257-261	Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children Author(s): Pramann Lance A, Davidow Lawrence W, van Haandel Leon, Funk Ryan S
Mar/Apr 2016 Pg. 125-134	Basics of Compounding: Capsules Author(s): Allen Loyd V Jr
Mar/Apr 2016 Pg. 137-141	Formulation and Stability of Solutions Author(s): Akers Michael J
Mar/Apr 2016 Pg. 159-163	Stability of Commercially Available Grape and Compounded Cherry Oral Vancomycin Preparations Stored in Syringes and Cups Author(s): Kirk Loren, Lewis Paul, Luu Yao, Brown Stacy
Mar/Apr 2016 Pg. 167-174	Stability of Atenolol, Clonazepam, Dexamethasone, Diclofenac Sodium, Diltiazem, Enalapril Maleate, Ketoprofen, Lamotrigine, Penicillamine-D, and Thiamine in SyrSpend SF PH4 Oral Suspensions Author(s): Polonini HC, Loures S, Lima LC, Ferreira AO, Brandão MA
Jan/Feb 2016 Pg. 58-62	Antimicrobial Activity of Copaiba (Copaifera officinalis) and Pracaxi (Pentaclethra macroloba) Oils against Staphylococcus aureus: Importance in Compounding for Wound Care Author(s): Guimarães Anna Luísa Aguiar, Cunha Elisa Alves, Matias Fernanda Oliveira, Garcia Patrícia Guedes, Danopoulos Panagiota, Swikidisa Rosita, Pinheiro Vanessa Alves, Nogueira Rodrigo José Lupatini
Jan/Feb 2016 Pg. 71-80	A Novel Vehicle for Enhanced Drug Delivery Across the Human Nail for the Treatment of Onychomycosis Author(s): Turner Rob, Weaver Sean, Caserta Francesco, Brown Marc B
Jan/Feb 2016 Pg. 81-85	Evaluation of the Stability of Mercaptopurine Suspension Compounded in a Commercial Vehicle and the Determination of an Appropriate Beyond-use Date Author(s): Peacock Gina F, Sauvageot Jurgita, Hill Ashley, Killian Alyssa
Nov/Dec 2015 Pg. 471-476	Basic Principles of Lyophilization, Part 1 Author(s): Akers Michael J
Nov/Dec 2015 Pg. 479-484	Mixing in a Compounding Pharmacy in the 21st Century Author(s): Standridge Rob
Sep/Oct 2015 Pg. 411	Vehicle for Oral Solution (National Formulary 26) Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 412	Vehicle for Oral Solution, Sugar Free (National Formulary 26) Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 413	Vehicle for Oral Suspension (National Formulary 26) Author(s): Allen Loyd V Jr
Sep/Oct 2015 Pg. 414-419	Solid State Stability of Extemporaneously Prepared Levothyroxine Aliquots and Capsules Author(s): Fortner Jeff, Salton Jason, Carlson Christie, Wheeler Rich, Cote Brianna, Rao Deepa
Sep/Oct 2015 Pg. 420-427	Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF Author(s): Geiger Christine M, Sorenson Bridget, Whaley Paul
Jul/Aug 2015 Pg. 334-336	Use of 8.4% Sodium Bicarbonate in Buffering Commonly Administered Vancomycin Hydrochloride Solutions for Use with Midline or Peripheral Line Catheters Author(s): Puertos Enrique, Spencer Melissa
Jul/Aug 2015 Pg. 337-339	Stability of Prednisone in Oral Mix Suspending Vehicle Author(s): Friciu Mihaela, Plourde Kevin, Leclair Grégoire, Danapoulos Panagiota, Savji Taslim
Jul/Aug 2015 Pg. 344-347	Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes Author(s): Anderson Collin R, Halford Zachery, MacKay Mark
May/Jun 2015 Pg. 223-230	Basics of Compounding: Compounding with Silicones Author(s): Allen Loyd V Jr
May/Jun 2015 Pg. 248-251	Stability of Metronidazole Suspensions Author(s): Donnelly Ronald F, Ying James
Mar/Apr 2015 Pg. 152-160	Transdermal Delivery of Nisoldipine: Refinement of Vehicles Author(s): El Maghraby Gamal M, Ahmed Amal A, Osman Mohamed A
Mar/Apr 2015 Pg. 161-166	Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations Author(s): Bryson Evan, Hartman Rachel, Arnold John, Gorman Greg, Sweitzer Sarah.Asbill Scott
Jan/Feb 2015 Pg. 6-12	Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Jan/Feb 2015 Pg. 38-40	Biotechnology, Nanotechnology, and Pharmacogenomics and Pharmaceutical Compounding, Part 1 Author(s): Allen Loyd V Jr
Jan/Feb 2015 Pg. 73-77	Physicochemical and Microbiological Stability of Azathioprine in InOrpha Suspending Agent Studied Under Various Conditions Author(s): Amin Alexandre, Bourget Philippe, Vidal Fabrice, Cartier Francois, Beauvais Raphaelle, Do Nascimento Afonso Veronica
Jan/Feb 2015 Pg. 78-85	Stability of Suspensions: Theoretical and Practical Considerations before Compounding Author(s): Hadziabdic Jasmina, Elezovic Alisa, Rahic Ognjenka, Mujezin Indira, Vranic Edina
Nov/Dec 2014 Pg. 504-511	Skin Penetration and Antinociception of Topical Gabapentin Formulations Author(s): Bryson Evan, Asbill Scott, Sweitzer Sarah
Nov/Dec 2014 Pg. 512-515	In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations Author(s): Heustess Allie, Asbill Scott, Eagerton David, Arnold John
Nov/Dec 2014 Pg. 516-519	Effect of Emulsifier Pairs on Physical Stability of Emulsions Containing Three Different Natural Oils Author(s): Boonme Prapaporn, Maneenuan Duangkhae
Nov/Dec 2014 Pg. 520-525	High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products Author(s): Quamrun Masuda, Mamoon Rashid, Nasheed Shams, Mullins Randy
Sep/Oct 2014 Pg. 427-431	Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition Author(s): Bourget Philippe, Amin Alexandre, Vidal Fabrice, Pieyre Manon, Dosso El Ourmar, Beauvais Raphaelle, Loeuillet Richard
Jul/Aug 2014 Pg. 287-290	Oral Mucosal Immunotherapy Using a Toothpaste Delivery System for the Treatment of Allergic Rhinitis Author(s): Reisacher William, Rudner Shara, Kotik Viktoriya
Jul/Aug 2014 Pg. 293-300	Color Additives: Legislative Perspective in the United States, Europe, Australia, and India Author(s): Kumar Anuj, Madan Anil K
Jul/Aug 2014 Pg. 318-319	Basics of Compounding: Tips and Hints, Part 4: Lollipops/Lozenges, Gummy Bears, Patches, Flavoring/Coloring, Sweeteners, and Packaging Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 329	Indigo Carmine Injection Author(s): Allen Loyd V Jr
Jul/Aug 2014 Pg. 332-340	Evaluation of Percutaneous Absorption Performance for Human Female Sexual Steroids into Pentravan Cream Author(s): Polonini Hudson C, Brandão Marcos Antônio F, Ferreira Anderson O, Ramos Cristiano, Raposo Nádia R B
Jul/Aug 2014 Pg. 341-344	Assessing the Use of Food Coloring as an Appropriate Visual Guide for Homogenously Mixed Capsule Powders in Extemporaneous Compounding Author(s): Hoffmann Brittany, Carlson Christie, Rao Deepa A
Jul/Aug 2014 Pg. 345-347	Evaluation of the Stability of Promethazine Hydrochloride in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Author(s): Peacock Gina F, Sauvageot Jurgita
Jul/Aug 2014 Pg. 348-350	Evaluation of the Stability of Ketoprofen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Author(s): Peacock Gina F, Sauvageot Jurgita, Addo Richard T
May/Jun 2014 Pg. 213-221	Quality Control Analytical Methods: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 1 Author(s): Vu Nicole, Lou Jessica R, Kupiec Thomas
May/Jun 2014 Pg. 228-230	Basics of Compounding: Tips and Hints, Part 3: Compounding with Ointments, Creams, Pastes, Gels, and Gel-creams Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 253-255	Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Author(s): Peacock Gina F, Sauvageot Jurgita
May/Jun 2014 Pg. 256-261	Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery Author(s): Boddu Sai HS, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth
Mar/Apr 2014 Pg. 123-130	Quality Control Analytical Methods: The Essentials of United States Pharmacopeia Chapter <51> Antimicrobial Effectiveness Testing and Its Application in Pharmaceutical Compounding Author(s): Vu Nicole, Nguyen Devin, Kupiec Thomas C
Mar/Apr 2014 Pg. 137-138	Basics of Compounding: Tips and Hints, Part 2: Compounding with Solutions, Suspensions, Emulsions, and Lotions Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 42-45	Tips and Hints: Powders, Capsules, Tablets, Suppositories, and Sticks Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 60	Aztreonam Injection Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 446-450	Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 2 Author(s): Horace Alexis E, Akbarian-Tefagh Jessica
Nov/Dec 2013 Pg. 490-495	Basics of Compounding: Basics of Compounding with Balsams Author(s): Allen Loyd V Jr
Nov/Dec 2013 Pg. 508-511	Stability of Non-aqueous Topical Tetracaine and Clotrimazole Solutions in Polypropylene Droptainer Bottles Author(s): McPherson Timothy B, Neumann William L, Kolling William M
Nov/Dec 2013 Pg. 512-514	Comparing Suppository Mold Variability Which Can Lead to Dosage Errors for Suppositories Prepared with the Same or Different Molds Author(s): Alexander Kenneth S, Baki Gabriella, Hart Christine, Hejduk Courtney, Chillas Stephanie
Nov/Dec 2013 Pg. 520-525	Ex Vivo Percutaneous Absorption of Ketamine, Bupivacaine, Diclofenac, Gabapentin, Orphenadrine, and Pentoxyifylline: Comparison of Versatile Cream vs. Reference Cream Author(s): Wang Xuexuan, Black Laura
Sep/Oct 2013 Pg. 370-374	Chemical Penetration Enhancers Author(s): Newton Stephen J
Sep/Oct 2013 Pg. 384-387	Methocarbamol Suspension for the Treatment of Rhabdomyolysis in Equines Author(s): Pruitt Bobby N III
Sep/Oct 2013 Pg. 388-391	Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 1 Author(s): Horace Alexis E, Akbarian-Tefagh Jessica
Sep/Oct 2013 Pg. 400-410	Basics of Compounding: Basics of Compounding with Tars Author(s): Allen Loyd V Jr
Sep/Oct 2013 Pg. 424-431	In Vitro Evaluation of Extemporaneously Compounded Immediate-release Capsules with Premixed Excipients, Based on the Biopharmaceutics Classification System (BCS) of the Drugs Author(s): Pinheiro Vanessa A, Danopoulos Panagiota, Demirdjian Lara, Nogueira Rodrigo J L, Dubois Fanny
Sep/Oct 2013 Pg. 432-435	Pattern of Extemporaneous Prescriptions and Preparations in a Tertiary Health Institution: A Five-year Assessment Author(s): Aghahowa S E, Egharevba J O, Erhagbe B E, Okoh F
Jul/Aug 2013 Pg. 312-322	Basics of Compounding: Foam Dosage Forms Author(s): Allen Loyd V Jr
Jul/Aug 2013 Pg. 336-338	Stability of Captopril in SyrSPend SF Author(s): Geiger Christine M, Sorenson Bridget, Whaley Paul A
Jul/Aug 2013 Pg. 344-346	Stability of Midazolam in SyrSpend SF and SyrSpend SF Cherry Author(s): Geiger Christine M, Sorenson Bridget, Whaley Paul A
Jul/Aug 2013 Pg. 347-350	Physical Stability of Coconut Oil Lotions Formulated Using a Hydrophile-lipophile System of Various Emulsifier Pairs Author(s): Boonme Prapaporn, Maneenuan Duangkhae, Channarong Sunee
May/Jun 2013 Pg. 201-204	Optimizing Third-party Reimbursement for Compounded Medications Author(s): McElhiney Linda F
May/Jun 2013 Pg. 247-253	Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel Author(s): Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
Mar/Apr 2013 Pg. 162-164	Stability of Rifampin in SyrSpend SF Author(s): Sorenson Bridget, Whaley Paul
Mar/Apr 2013 Pg. 165-167	Stability of Minoxidil in Espumil Foam Base Author(s): Geiger Christine M, Sorenson Bridget, Whaley Paul A
Jan/Feb 2013 Pg. 10-22	Compounding Slow-release Capsules: A Comprehensive Review and an Excel Spreadsheet for Faster Calculation of Excipients Author(s): Zur Eyal
Nov/Dec 2012 Pg. 510-512	Stability of Ursodiol in SyrSpend SF Cherry Flavored Author(s): Geiger Christine M, Voudrie Mark A II, Sorenson Bridget
Nov/Dec 2012 Pg. 513-515	Stability of Propranolol Hydrochloride in SyrSpend SF Author(s): Geiger Christine M, Voudrie Mark A II, Sorenson Bridget
Nov/Dec 2012 Pg. 516-523	Rice Bran Oil: Preparation and Evaluation of Novel Liquisolid and Semisolid Formulations Author(s): Ammar Hussein O, Al-Okbi Sahar Y, Mostafa Dina M, Helal Amr M
Sep/Oct 2012 Pg. 386-393	Topical Use of Sodium Cromoglicate (Cromolyn Sodium) to Treat Atopic Dermatitis and Other Skin Allergies Author(s): Zur Eyal
Sep/Oct 2012 Pg. 428-430	Evaluation of the Stability of Acetaminophen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-Use Date Author(s): Peacock Gina F, Sauvageot Jurgita
Jul/Aug 2012 Pg. 304-309	Selection of Color Additives: A Regulatory View Author(s): Kumar Anuj, Dureja Harish, Madan Anil K
Jul/Aug 2012 Pg. 347-349	Stability of Gabapentin in SyrSpend SF Author(s): Sorenson Bridget, Voudrie Mark A II, Gehrig Dan
May/Jun 2012 Pg. 248-252	In Vitro Percutaneous Absorption of Ketoprofen and Testosterone: Comparison of Pluronic Lecithin Organogel vs. Pentravan Cream Author(s): Lehman Paul A, Raney Sam G
Mar/Apr 2012 Pg. 146-150	Basics of Compounding: Implementing United States Pharmacopeia Chapter <1163> Quality Assurance in Pharmaceutical Compounding, Part 1 Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 164-166	Stability of Omeprazole in SyrSpend SF Alka (Reconstituted) Author(s): Whaley Paul A, Voudrie Mark A II, Sorenson Bridget
Mar/Apr 2012 Pg. 167-169	Stability of Vancomycin in SyrSpend SF Author(s): Whaley Paul A, Voudrie Mark A II
Jan/Feb 2012 Pg. 62-63	The Use of Pluronic Lecithin Organogels in the Transdermal Delivery of Drugs Author(s): Bramwell Bethany L, Williams LaVonn A
Nov/Dec 2011 Pg. 510-514	A New Proposal: Calculating Density Factors for Drugs Using Cocoa Butter as the Standard Author(s): Walker Heather, Sridhar Vishak, Alexander Kenneth S
Nov/Dec 2011 Pg. 521-525	Development and Statistical Analysis of Glipzide-Loaded Fast-Dissolving Tablets Using Plantago ovata Husk as a Superdisintegrant Author(s): Jha Antesh Kr, Chetia D
Sep/Oct 2011 Pg. 390-407	Quality-Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 3: Testimonials and Comparisons Author(s): James Kate, Allred Richard, Latta Kenneth S, McElhiney Linda F, Olson Jacob, Hall Richard M, Baker Chad, Armstrong Nicholas, Janik Peter, Whitehead Paul, Purcell Julian
Sep/Oct 2011 Pg. 435-437	Stability of Clopidogrel in Three Extemporaneously Compounded Oral Liquid Preparations Author(s): Yamreudeewong Weeranuj, Dolence Eric Kurt, Teixeira M Glaucia
Jul/Aug 2011 Pg. 322-326	Quality-Control Analytical Methods: Using Purified Water for Reconstitutions Author(s): Biller Jeremy
May/Jun 2011 Pg. 255-258	Stability of Verapamil Hydrochloride in SyrSpend SF Compared to Sorbitol Containing Syrup and Suspending Vehicles Author(s): Voudrie Mark A, Alexander Bridget, Allen D Brett
May/Jun 2011 Pg. 190-192	Drug Compatibility and Stability in Dextrose vs Saline Author(s): Newton David W
May/Jun 2011 Pg. 224-232	Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 2: USP Waters: Experts at the United States Pharmacopeia Answer Compounders' Questions Author(s): Schnatz Rick, Hernandex-Cardoso Antonio
May/Jun 2011 Pg. 234-238	Basics of Compounding: Basics of Compounding with Complex Organic Molecules Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 94-100	Home Infusion Basics for the Non-Infusion Pharmacist Author(s): Miron Karen E
Mar/Apr 2011 Pg. 133-144	Quality Control Analytical Methods: Aqua Pura: Water Purification Systems and United States Pharmacopeia Waters for the Compounding Pharmacy, Part 1 Author(s): Latta Kenneth S, Cabaleiro Joe, Whitehead Paul, Edison Doug
Mar/Apr 2011 Pg. 146-153	Basics of Compounding: Basics of Compounding with Inorganic Salts Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 164	Oral Film Strip Vehicle Author(s): Allen Loyd V Jr
Jan/Feb 2011 Pg. 32-40	Maillard Reactions in Pharmaceutical Formulations and Human Health Author(s): Newton David W
Nov/Dec 2010 Pg. 508-510	Basics of Compounding: Basics of Compounding with Aliquots, Dilutions, and Concentrates Author(s): Allen Loyd V Jr
Nov/Dec 2010 Pg. 472-478	Extemporaneous Compounding of Medicated Ointment Author(s): Nagel Karen, Ali Fatima, Al-Khudari Sarah, Khan Ayesha, Patel Khushbu, Patel Nikunj, Desai Archana
Jul/Aug 2010 Pg. 276-282	Recommendations for Compounding Medications for Feeding Tube Administration Author(s): Klang Mark
Jul/Aug 2010 Pg. 301-304	Considerations for Percutaneous Absorption Author(s): Newton Stephen J, Cook Jennifer M
May/Jun 2010 Pg. 182-192	Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
May/Jun 2010 Pg. 204-206	Managing Pain with Transdermal Ketoprofen Author(s): Williams KaCee D
Mar/Apr 2010 Pg. 118-123	Developing a Tretinoin Oral Liquid for Patients Who Cannot Take Capsules Author(s): McElhiney Linda F
Mar/Apr 2010 Pg. 158	Plasticized Hydrocarbon Gel Author(s): Allen Loyd V Jr
Mar/Apr 2010 Pg. 159	Oral Adhesive Paste Author(s): Allen Loyd V Jr
Jan/Feb 2010 Pg. 21-25	Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet Author(s): McElhiney Linda F, Cheng Angela, Meshberger Laura, Imai Lara
Jan/Feb 2010 Pg. 72	Testosterone 1% in Alcoholic Gel Author(s): Allen Loyd V Jr
Jan/Feb 2010 Pg. 67	Hydrocarbon-Free Lotion Author(s): Allen Loyd V Jr
Jan/Feb 2010 Pg. 76-77	Chemical Stability of Hydrocortisone in Humco Simple Syrup and Ora-Sweet Vehicle Author(s): Gupta Vishnu D
Jan/Feb 2010 Pg. 82-85	Stability of Oseltamivir Phosphate in SyrSpend SF, Cherry Syrup, and SyrSpend SF (For Reconstitution) Author(s): Voudrie Mark A II, Allen D Brett
Nov/Dec 2009 Pg. 498-505	Compliance to Treatment in Elderly Dysphagic Patients: Potential Benefits of Alternate Dosage Forms Author(s): Bramwell Bethany L
Nov/Dec 2009 Pg. 506-515	Autologous Eye Drops for the Treatment of Dry Eye and Neurotrophic Keratitis Author(s): Mixon William, Angelle Patricea (Patsy), Chang Richard I
Nov/Dec 2009 Pg. 569-571	The Release and Transdermal Penetration of Baclofen Formulated in a Poloxamer Lecithin Organogel Author(s): Arnold John J, Asbill Scott
Nov/Dec 2009 Pg. 561	Twevan Cream Author(s): Allen Loyd V Jr
Sep/Oct 2009 Pg. 390-391	Recommended Tips for Treating Veterinary Patients Author(s): Bramwell Bethany L, Williams LaVonn A
Jul/Aug 2009 Pg. 332	Alcohol-based Carbomer Gel Author(s): Allen Loyd V Jr
May/Jun 2009 Pg. 259-261	Formulation Optimization Study for an Immediate-Release Tablet Author(s): Kyriacos Soula, Dimassi Hani
Mar/Apr 2009 Pg. 166-169	Stability of Low-Concentration Ceftazidime in 0.9% Sodium Chloride Injection and Balanced Salt Solutions in Plastic Syringes Under Various Storage Conditions Author(s): Xu Meng, Warren Flynn W, Bartlett Michael G
Mar/Apr 2009 Pg. 170-174	Stability of Melatonin in an Extemporaneously Compounded Sublingual Solution and Hard Gelatin Capsule Author(s): Haywood Alison, Burrell Anthony, van Bred Karin, George Rani, Testa Chris, Norris Ross
Jan/Feb 2009 Pg. 6-12	Compounding for Pediatric Patients: Case Reports and Formulations Author(s): Mixon William, Angelle Patricea, Yoch Douglas
Jan/Feb 2009 Pg. 81-86	The Value of Near Infrared Spectroscopy in a Small Hospital Compounding Unit to Control the Risks Associated with Raw Materials Author(s): Storme-Paris Isabelle, Storme Thomas, Thauvin Maxime, Brion Francoise, Chaminade Pierre, Rieutord Andre
Nov/Dec 2008 Pg. 498-504	Case Reports: Compounding to Relieve Arthritis Pain Author(s): Marshall Robert, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane
Nov/Dec 2008 Pg. 558-564	Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System Author(s): Vu Nicole T, Aloumanis Vasileios, Ben Michel J, Kupiec Thomas C, Patterson Evelyn K, Radke Joshua, Erickson Martin A III, Schneider Gary
Sep/Oct 2008 Pg. 398-401	Veterinary Compounding for Myasthenia Gravis Author(s): Davidson Gigi S
Sep/Oct 2008 Pg. 460-462	Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration Author(s): Ben Michel, Kupiec Thomas C, Trusley Craig, Trissel Lawrence A
Sep/Oct 2008 Pg. 426-430	Excipient Choices for Special Populations Author(s): Nagel-Edwards Karen M, Ko James Y
Jul/Aug 2008 Pg. 316-320	Beyond-Use Dating, Labeling, Delivery, and Storage of Compounded and Repackaged Mediations in a Hospital or Institutional Setting Author(s): McElhiney Linda F
May/Jun 2008 Pg. 270-273	Evaluation of the Percutaneous Absorption of Promethazine Hydrochloride, In Vitro, Using the Human Ex Vivo Skin Model Author(s): Bassani August S, Banov Daniel, Lehman Paul A
Nov/Dec 2007 Pg. 476-481	Proteins Used as Sweeteners Author(s): Li Xiaojian, Alexander Kenneth S
Sep/Oct 2007 Pg. 425	Nondetergent Neutral Dry Skin Cream Author(s): Allen Loyd V Jr
Sep/Oct 2007 Pg. 426-432	Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion Author(s): Desai Narendra R, Shah Syed M, Koczone Julianna, Vencl-Joncic Maja, Sisto Christopher, Ludwig Stephen A
Sep/Oct 2007 Pg. 433-437	Isoniazid Release from Suppositories Compounded with Selected Bases Author(s): Hudson Kristofer C, Asbill C Scott, Webster Andrew A
Jul/Aug 2007 Pg. 337	Vehicle N Formulas Author(s): Allen Loyd V Jr
Mar/Apr 2007 Pg. 116-120	Challenges of Compounding for Patients on the Ketogenic Diet Author(s): McElhiney Linda F
Mar/Apr 2007 Pg. 126-130	Including Pets in Diabetic Care Author(s): Davidson Gigi S
Mar/Apr 2007 Pg. 159	Oral Liquid Vehicle, Anhydrous Author(s): Allen Loyd V Jr
Mar/Apr 2007 Pg. 164-176	Stability of Oseltamivir in Various Extemporaneous Liquid Preparations Author(s): Ford Stephen M, Kloesel Lawson G, Grabenstein John D
Jan/Feb 2007 Pg. 5-8	Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1 Author(s): Giacoia George P, Taylor-Zapata Perdita, Mattison Donald
Jan/Feb 2007 Pg. 17-19	Pediatric Oral Formulations: A Continual Challenge Author(s): Hurtado Josephine, Moffett Brady S
Nov/Dec 2006 Pg. 405-408	Application of Sildenafil for Pulmonary Hypertension in Canines and Foals Author(s): Davidson Gigi S
Nov/Dec 2006 Pg. 411-414	Compounding for Feline Herpetic Keratitis Author(s): Davidson Gigi S
Sep/Oct 2006 Pg. 392-395	In Vitro Transdermal Diffusion of Zileuton from a Topical Gel Author(s): Bigeleisen Paul E
May/Jun 2006 Pg. 237-239	Chemical Stability of Diphenhydramine Hydrochloride from an Elixir and Lidocaine Hydrochloride from a Viscous Solution when Mixed Together Author(s): Gupta Vishnu D
Mar/Apr 2006 Pg. 156-158	Extended Stability of Oxytocin in Common Infusion Solutions Author(s): Trissel Lawrence A, Zhang Yanping, Douglass Kate, Kastango Eric
Jan/Feb 2006 Pg. 44	Acacia and Mineral Oil Emulsion NF Author(s): Al-Achi Antoine, Mosley Anita, Patlolla Swapna
Jan/Feb 2006 Pg. 63	Medium-Chain Triglycerides Oral Vehicle, Anhydrous Author(s): Allen Loyd V Jr
Nov/Dec 2005 Pg. 437-442	Pediatric Oral Liquid Preparations Author(s): Fonseca Simonne C, Ferreira Anderson de O
Nov/Dec 2005 Pg. 456-461	Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions Author(s): Fonseca Simonne C
Nov/Dec 2005 Pg. 462-469	Quality Control Analytical Methods: Quality Issues Related to Compounding with Commercial Products Author(s): Allen Loyd V Jr
Sep/Oct 2005 Pg. 357-358 View Sample	Formulating for the Gluten-sensitive Individual Author(s): Cacace Janice L
Sep/Oct 2005 Pg. 396-298	Stability and Subjective Taste Acceptability of Four Glycopyrrolate Solutions for Oral Administration Author(s): Landry Christine, Forest Jean-Marc, Hildgen Patrice
Sep/Oct 2005 Pg. 399-401	Chemical Stability of Hydralazine Hydrochloride after Reconstruction in 0.9% Sodium Chloride Injection or 5% Dextrose Injection for Infusion Author(s): Gupta Vishnu D
Jan/Feb 2005 Pg. 75-81	Physical characteristics of selected over-the-counter medications Author(s): Al-Achi Antoine, Shipp Shawnte
Jan/Feb 2005 Pg. 82-86	Stability of an Extemporaneously Compounded Propylthiouracil Suspension Author(s): Alexander Kenneth S, Mitra Pallabi
Nov/Dec 2004 Pg. 458-460	A Need for Propylene Glycol-Free Ascorbic Acid Oral Liquid Author(s): McElhiney Linda F
Nov/Dec 2004 Pg. 489-491	Chemical Stability of Methadone Concentrate and Powder Diluted in Orange-Flavored Drink Author(s): Donnelly Ronald F
Mar/Apr 2003 Pg. 145-148	Featured Excipient: Plasticizers Author(s): Allen Loyd V Jr
Jan/Feb 2003 Pg. 48-50	Featured Excipient: Flavor Enhancing Agents Author(s): Allen Loyd V Jr
Nov/Dec 2002 Pg. 462-464	Featured Excipient: Disinfecting Agents Author(s): Allen Loyd V Jr
Sep/Oct 2002 Pg. 380-383	Featured Excipient: Specially Denatured Alcohols Author(s): Allen Loyd V Jr
Jul/Aug 2002 Pg. 303-304	Topical Oil-in-Water Cream Bases, Featured Excipient: Author(s): Allen Loyd V Jr
May/Jun 2002 Pg. 221-223	Sorbitan Esters, Featured Excipient: Author(s): Allen Loyd V Jr
Mar/Apr 2002 Pg. 147-148	Polysorbates, Featured Excipient: Author(s): Allen Loyd V Jr
Jan/Feb 2002 Pg. 58-59	Poloxamers, Featured Excipient: Author(s): Allen Loyd V Jr
Nov/Dec 2001 Pg. 471-473	Tablet and Lozenge Binders, Featured Excipient: Author(s): Allen Loyd V Jr
Sep/Oct 2001 Pg. 389-390	Capsule and Tablet Disintegrating Agents, Featured Excipient: Author(s): Allen Loyd V Jr
Jul/Aug 2001 Pg. 310-312	Wetting and/or Solubilizing Agents, Featured Excipient: Author(s): Allen Loyd V Jr
May/Jun 2001 Pg. 228	Official Water-Repelling Agents: The Official Silicones, Featured Excipient: Author(s): Allen Loyd V Jr
Mar/Apr 2001 Pg. 145-146	Ointment Vehicles, Featured Excipient: Author(s): Allen Loyd V Jr
Jan/Feb 2001 Pg. 65-67	Oral Liquid Vehicles, Featured Excipient: Author(s): Allen Loyd V Jr
Nov/Dec 2000 Pg. 470-472	Oleaginous Vehicles, Featured Excipient: Author(s): Allen Loyd V Jr
Sep/Oct 2000 Pg. 390	Capsule and Tablet Lubricants, Featured Excipient: Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 306-310	Capsule and Tablet Diluents, Featured Excipient: Author(s): Allen Loyd V Jr
May/Jun 2000 Pg. 196-197	Cellulose Applications for the Pharmaceutical Industry Author(s): Nicoll Harold
May/Jun 2000 Pg. 218-220	Tonicity-Adjusting Agents, Featured Excipient: Author(s): Allen Loyd V Jr
Mar/Apr 2000 Pg. 139-142	Official Solvents, Featured Excipient: Author(s): Allen Loyd V Jr
Jan/Feb 2000 Pg. 60-62	Stiffening Agents, Featured Excipient: Author(s): Allen Loyd V Jr
Nov/Dec 1999 Pg. 479	Viscosity-Increasing Agents for Aqueous Systems, Featured Excipient: Author(s): Allen Loyd V Jr
Sep/Oct 1999 Pg. 404-405	Alkalizing Agents, Featured Excipient: Author(s): Allen Loyd V Jr
Jul/Aug 1999 Pg. 309-310	Acidifying Agents, Featured Excipient: Author(s): Allen Loyd V Jr
May/Jun 1999 Pg. 228-231	Sweetening Agents, Featured Excipient: Author(s): Allen Loyd V Jr
Mar/Apr 1999 Pg. 142-143	Preservatives, Featured Excipient: Author(s): Allen Loyd V Jr
Jan/Feb 1999 Pg. 52-55	Antioxidants, Featured Excipient: Author(s): Allen Loyd V Jr
Nov/Dec 1998 Pg. 450-452	Gelatin, Featured Excipient: Author(s): Allen Loyd V Jr
Sep/Oct 1998 Pg. 372-373	Dextrose Injection and Dextrose, Featured Excipient: Author(s): Allen Loyd V Jr
Jul/Aug 1998 Pg. 306-307	Polyethylene Glycols, Featured Excipient: Author(s): Allen Loyd V Jr
Mar/Apr 1998 Pg. 162-164	Silicates: Attapulgite, Kaolin, Kieselguhr, Magnesium Trisilicate, Pumice, Talc - Featured Excipient: Author(s): Allen Loyd V Jr
Jan/Feb 1998 Pg. 73-74	Silicates: Bentonite, Magnesium Aluminum Silicate, Silica Gel and Colloidal Silicon Dioxide - , Featured Excipient: Author(s): Allen Loyd V Jr
Nov/Dec 1997 Pg. 426-427	Water, Featured Excipient: Author(s): Allen Loyd V Jr
Sep/Oct 1997 Pg. 336-337	Benzalkonium Chloride, Featured Excipient: Author(s): Allen Loyd V Jr
May/Jun 1997 Pg. 190-191	Poloxamer, Featured Excipient: Author(s): Allen Loyd V Jr
Mar/Apr 1997 Pg. 115	Methylcellulose, Featured Excipient: Author(s): Allen Loyd V Jr